Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

Turner, R., Stratton, I., Horton, V., Manley, S., Zimmet, P., Mackay, I. R., Shattock, M., Bottazzo, G. F., & Holman, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03062-6 · Cited by 779

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes

Gale, E. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15786-3 · Cited by 534

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

Verge, C. F., Stenger, D., Bonifacio, E., Colman, P. G., Pilcher, C., Bingley, P. J., & Eisenbarth, G. S. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1857 · Cited by 420

Diabetes Antibody Standardization Program: first assay proficiency evaluation

Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362

Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity

Bonifacio, E. E., Genovese, S., Braghi, S., Bazzigaluppi, E., Lampasona, V., Bingley, P. J., Rogge, L., Pastore, M. R., Bognetti, E., Bottazzo, G. F., et al. (1995) · Diabetologia · doi:10.1007/s001250050358 · Cited by 178

Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement

Greenbaum, C. J., Palmer, J. P., Kuglin, B., & Kolb, H. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.5.1569152 · Cited by 156

Comparative Evaluation of Serologic Tests for Celiac Disease: A European Initiative Toward Standardization

Stern, M., & Working Group on Serologic Screening for Celiac Disease (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200011000-00012 · Cited by 151

Immunology and Diabetes Workshops: report of the first international workshop on the standardisation of cytoplasmic islet cell antibodies

Bottazzo, G. F., & Gleichmann, H. (1986) · Diabetologia · doi:10.1007/bf00456124 · Cited by 143

Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories

Bingley, P. J., Williams, A. J. K., Colman, P. G., Gellert, S. A., Eisenbarth, G. S., Yu, L., Perdue, L., Pierce, J. J., Hilner, J. E., Nierras, C. R., et al. (2010) · Clinical Trials · doi:10.1177/1740774510373496 · Cited by 26

Seroconversion to Islet Autoantibodies After Enterovirus Infection in Early Pregnancy

Lindehammer, S. R., Honkanen, H., Nix, W. A., Oikarinen, M., Lynch, K. F., Jönsson, I., Maršál, K., Oberste, S. M., Hyöty, H., & Lernmark, Å. (2012) · Viral Immunology · doi:10.1089/vim.2012.0022 · Cited by 26

IA-2 autoantibody affinity in children at risk for type 1 diabetes

Krause, S., Chmiel, R., Bonifacio, E. E., Scholz, M., Powell, M. J., Furmaniak, J., Smith, B. R., Ziegler, A., & Achenbach, P. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.09.010 · Cited by 25

Therapy for Type 1 Diabetes

Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0984-5696 · Cited by 29

Autoantibody‐defined risk for Type 1 diabetes mellitus in a general population of schoolchildren: results of the Karlsburg Type 1 Diabetes Risk Study after 18 years

Till, A. ‐., Kenk, H., Rjasanowski, I. M., Waßmuth, R., Walschus, U., Kerner, W., & Schlosser, M. (2014) · Diabetic Medicine · doi:10.1111/dme.12677 · Cited by 25

High Levels of Education Are Associated With an Increased Risk of Latent Autoimmune Diabetes in Adults

Olsson, L., Ahlbom, A., Grill, V., Midthjell, K., & Carlsson, S. (2010) · Diabetes Care · doi:10.2337/dc10-1061 · Cited by 24

Autoimmunity to tetraspanin-7 in type 1 diabetes

McLaughlin, K. A., Tombs, M. A., & Christie, M. R. (2020) · Medical Microbiology and Immunology · doi:10.1007/s00430-020-00674-2 · Cited by 25

Endocrine autoimmunity in families with type 1 diabetes: frequent appearance of thyroid autoimmunity during late childhood and adolescence

Bonifacio, E. E., Mayr, A., Knopff, A., & Ziegler, A. (2008) · Diabetologia · doi:10.1007/s00125-008-1206-6 · Cited by 23

Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease

Ziegler, A., Bonifacio, E. E., Powers, A. C., Todd, J. A., Harrison, L. C., & Atkinson, M. A. (2016) · Diabetes · doi:10.2337/db16-0687 · Cited by 23

Peculiar characteristics of new-onset Type 1 Diabetes during COVID-19 pandemic

Mastromauro, C., Blasetti, A., Primavera, M., Ceglie, L., Mohn, A., Chiarelli, F., & Giannini, C. (2022) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-022-01223-8 · Cited by 23

Analgesic antipyretic use among young children in the TEDDY study: no association with islet autoimmunity

for the TEDDY Study Group, Lundgren, M., Steed, L., Tamura, R., Jónsdóttir, B., Gesualdo, P., Crouch, C. C., Sjöberg, M., Hansson, G., Hagopian, W., et al. (2017) · BMC Pediatrics · doi:10.1186/s12887-017-0884-y · Cited by 22

Reduction in White Blood Cell, Neutrophil, and Red Blood Cell Counts Related to Sex, HLA, and Islet Autoantibodies in Swedish TEDDY Children at Increased Risk for Type 1 Diabetes

Salami, F., Lee, H. S., Freyhult, E., Larsson, H. E., Lernmark, Å., Törn, C., The TEDDY Study Group, Rewers, M. J., BAUTISTA, K. A., Baxter, J., et al. (2018) · Diabetes · doi:10.2337/db18-0355 · Cited by 23

Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme‐linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity

Kawasaki, E., Okada, A., Uchida, A., Fukuyama, T., Sagara, Y., Nakano, Y., Tamai, H., Tojikubo, M., & Koga, N. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12996 · Cited by 21

Sleep disturbances and low psychological well-being are associated with an increased risk of autoimmune diabetes in adults. Results from the Nord-Trøndelag Health Study

Olsson, L., Ahlbom, A., Grill, V., Midthjell, K., & Carlsson, S. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.011 · Cited by 22

Optimizing Multiplexed Detections of Diabetes Antibodies via Quantitative Microfluidic Droplet Array

Duan, K., Ghosh, G., & Lo, J. F. (2017) · Small · doi:10.1002/smll.201702323 · Cited by 21

Age, HLA, and Sex Define a Marked Risk of Organ-Specific Autoimmunity in First-Degree Relatives of Patients With Type 1 Diabetes

Winkler, C., Jolink, M., Knopff, A., Kwarteng, N.-A., Achenbach, P., Bonifacio, E. E., & Ziegler, A. (2019) · Diabetes Care · doi:10.2337/dc19-0315 · Cited by 21

Neuromyelitis optica: Concepts in evolution

Fazio, R., Radaelli, M., & Furlan, R. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.012 · Cited by 20

Measuring Autoantibodies against IL‐17F and IL‐22 in Autoimmune Polyendocrine Syndrome Type I by Radioligand Binding Assay Using Fusion Proteins

Oftedal, B. E., Kämpe, O., Meager, A., Ahlgren, K. M., Lobell, A., Husebye, E. S., & Wolff, A. S. B. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02573.x · Cited by 20

Organ-specific autoimmunity in relation to clinical characteristics in children with long-lasting type 1 diabetes

Głowińska‐Olszewska, B., Michalak, J., Łuczyński, W., Larosa, M. D. P., Chen, S., Furmaniak, J., Smith, B. R., & Bossowski, A. T. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0190 · Cited by 20

Glutamic acid decarboxylase and islet antigen 2 antibody profiles in people with adult‐onset diabetes mellitus: a comparison between mixed ethnic populations in Singapore and Germany

Ong, Y. H., Koh, W. C. A., Ng, M. L., Tam, Z. Y., Lim, S. C., & Boehm, B. O. (2017) · Diabetic Medicine · doi:10.1111/dme.13358 · Cited by 21

Higher body mass index in adults at diagnosis of the slowly progressive form of type 1 diabetes mellitus is associated with lower risk HLA genes

Fourlanos, S., Elkassaby, S., Varney, M. D., Colman, P. G., & Harrison, L. C. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.03.009 · Cited by 20

Diabetes Antibody Standardization Program

Schlosser, M., Mueller, P. W., Achenbach, P., Lampasona, V., Bingley, P. J., & Laboratories, P. (2011) · Diabetes Care · doi:10.2337/dc11-1161 · Cited by 19

Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes

Wallet, M. A., Santostefano, K. E., Terada, N., & Brusko, T. M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00276 · Cited by 23

Immunoassay Techniques Highlighting Biomarkers in Immunogenetic Diseases

Manole, E., Bastian, A. E., Popescu, I. D., Constantin, C., Mihai, S., Gaina, G. F., Codrici, E., & Neagu, M. T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.75951 · Cited by 18

Islet Autoantibody Testing: An End to the Trials and Tribulations?

Bingley, P. J., & Williams, A. J. K. (2013) · Diabetes · doi:10.2337/db13-1445 · Cited by 18

Autoantibodies and Cytokines

Khan, W. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.68834 · Cited by 19

Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay

Yu, L. (2015) · Methods in molecular biology · doi:10.1007/7651_2015_296 · Cited by 17

Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children

Ng, K., Stavropoulos, H., Anand, V., Veijola, R., Toppari, J., Maziarz, M., Lundgren, M., Waugh, K., Frohnert, B. I., Martin, F., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0878 · Cited by 18

The measurement of autoantibodies to insulin informs diagnosis of diabetes in a childhood population negative for other autoantibodies

Williams, C. L., Aitken, R. J., Wilson, I. V., Mortimer, G., Long, A. E., Williams, A. J. K., The BOX Study Group, & Gillespie, K. M. (2022) · Diabetic Medicine · doi:10.1111/dme.14979 · Cited by 18

Therapie des Typ-1-Diabetes

Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2019) · Der Diabetologe · doi:10.1007/s11428-019-0458-8 · Cited by 18

Parameters influencing antigen-specific immunotherapy for type 1 diabetes

Wang, B., & Tisch, R. (2008) · Immunologic Research · doi:10.1007/s12026-008-8020-6 · Cited by 17

Therapie des Typ-1-Diabetes

Böhm, B., Dreyer, M., Fritsche, A., Füchtenbusch, M., Gölz, S., & Martin, S. (2012) · Diabetologie und Stoffwechsel · doi:10.1055/s-0032-1325579 · Cited by 16

Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 Diabetes

Steck, A. K., Liu, X., Krischer, J. P., Haller, M. J., Veijola, R., Lundgren, M., Ahmed, S. T., Akolkar, B., Toppari, J., Hagopian, W., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa715 · Cited by 17

Factors associated with the presence of glutamic acid decarboxylase and islet antigen-2 autoantibodies in patients with long-standing type 1 diabetes

Wilmot-Roussel, H., Levy, D. J., Carette, C., Caillat‐Zucman, S., Boîtard, C., Timsit, J., & Dubois‐Laforgue, D. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.01.002 · Cited by 16

Family psychological stress early in life and development of type 1 diabetes: the ABIS prospective study.

Nygren, M., Ludvigsson, J., Carstensen, J., & Frostell, A. S. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.03.016 · Cited by 18

A Simple and Fast Non-Radioactive Bridging Immunoassay for Insulin Autoantibodies

Kikkas, I., Mallone, R., Tubiana‐Rufi, N., Chevenne, D., Carel, J., Créminon, C., Volland, H., Boîtard, C., & Morel, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069021 · Cited by 15

A Rapid Lateral Flow Immunoassay for the Detection of Tyrosine Phosphatase-Like Protein IA-2 Autoantibodies in Human Serum

Kikkas, I., Mallone, R., Larger, É., Volland, H., & Morel, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103088 · Cited by 15

Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes

Kawasaki, E., Shimada, A., Imagawa, A., Abiru, N., Awata, T., Oikawa, Y., Osawa, H., Kawabata, Y., Kozawa, J., Kobayashi, T., et al. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.13980 · Cited by 14

Telomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the TEDDY study

Törn, C., Liu, X., Önengüt-Gümüşcü, S., Counts, K., Moreno, J. L., Remedios, C. L., Chen, W., LeFaive, J., Butterworth, M. D., Akolkar, B., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-08058-7 · Cited by 14

Time to reframe the disease staging system for type 1 diabetes

Jacobsen, L. M., Atkinson, M. A., Sosenko, J. M., & Gitelman, S. E. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00239-0 · Cited by 15

Long-lasting remission of type 1 diabetes following treatment with topiramate for generalized seizures

Davalli, A. M., Perego, C., Folli, F. B., & Bosi, E. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0268-y · Cited by 13

Hyperglycemic hyperosmolar state in an adolescent with type 1 diabetes mellitus

Watanabe, S., Kido, J., Ogata, M., Nakamura, K., & Mizukami, T. (2019) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-18-0131 · Cited by 13

Does Diabetes Appear in Distinct Phenotypes in Young People? Results of the Diabetes Mellitus Incidence Cohort Registry (DiMelli)

Warncke, K., Krasmann, M., Puff, R., Dunstheimer, D., Ziegler, A., & Beyerlein, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074339 · Cited by 13

Islet Autoantibody Detection by Electrochemiluminescence (ECL) Assay

Gu, Y., Zhao, Z., High, H., Yang, T., & Yu, L. (2017) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000531 · Cited by 13

Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?

Boudiaf, A., Bouziane, D., Smara, M., Meddour, Y., Haffaf, E. M., Oudjit, B., Mamouzi, S. C., & Bouguerra, S. A. (2018) · Current Research in Translational Medicine · doi:10.1016/j.retram.2018.01.003 · Cited by 12

Evidence of increased humoral endocrine organ-specific autoimmunity in severe and classic X-chromosome aneuploidies in comparison with 46,XY control subjects

Panimolle, F., Tiberti, C., Granato, S., Anzuini, A., Pozza, C., Lenzi, A., & Radicioni, A. F. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1477134 · Cited by 12

Non autoimmune type 1B diabetes after mild COVID‐19: Report of three cases

Seow, C. J., Koh, A. W. C., Lian, J. X., Dalan, R., & Boehm, B. O. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3438 · Cited by 12

Therapie des Typ-2-Diabetes

Landgraf, R., Kellerer, M., Aberle, J., Fach, E.-M., Gallwitz, B., Hamann, A., Joost, H., Klein, H., Müller‐Wieland, D., Nauck, M. A., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0598-0475 · Cited by 11

The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes

Wyatt, R. C., Brigatti, C., Liberati, D., Grace, S. L., Gillard, B. T., Long, A. E., Marzinotto, I., Shoemark, D. K., Chandler, K. A., Achenbach, P., et al. (2018) · Diabetic Medicine · doi:10.1111/dme.13628 · Cited by 11

Parameters influencing antigen-specific immunotherapy for Type 1 diabetes

Wang, B., & Tisch, R. (2008) · Immunologic Research · doi:10.1007/s12026-008-8090-5 · Cited by 11

Type 1 (Insulin-Dependent) Diabetes Mellitus

Delli, A. J., & Lernmark, Å. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00039-1 · Cited by 11

Carbohydrates

Khan, M. I., & Weinstock, R. S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00016-6 · Cited by 12

Danish children born with glutamic acid decarboxylase-65 and islet antigen-2 autoantibodies at birth had an increased risk to develop type 1 diabetes

Eising, S., Nilsson, A., Carstensen, B., HOUGAARD, D. M., Nørgaard‐Pedersen, B., Nerup, J., Lernmark, Å., & Pociot, F. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0792 · Cited by 10

Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD)

Hegvik, T., Husebye, E. S., & Haavik, J. (2013) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-013-0429-3 · Cited by 12

Effective assay technologies fit for large-scale population screening of type 1 diabetes

Jia, X., & Yu, L. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.1034698 · Cited by 10

Immunobiology of β-Cell Destruction

Torre, D. L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_16 · Cited by 10

Could the social environment trigger the induction of diabetes related autoantibodies in young children?

Karlén, J., Faresjö, T., & Ludvigsson, J. (2012) · Scandinavian Journal of Public Health · doi:10.1177/1403494811435491 · Cited by 10

Comparing the clinical significance and antigen specificity of insulinoma‐associated antigen‐2 autoantibodies between radioimmunoassay and enzyme‐linked immunosorbent assay in Japanese patients with type 1 diabetes

Kawasaki, E., Shimada, A., Imagawa, A., Abiru, N., Awata, T., Oikawa, Y., Osawa, H., Kawabata, Y., Kozawa, J., Kobayashi, T., et al. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13910 · Cited by 10

Therapie des Typ-1-Diabetes – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-013; 2. Auflage)

Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2019) · Diabetologie und Stoffwechsel · doi:10.1055/a-0898-7429 · Cited by 9

Novel clusters of newly-diagnosed type 2 diabetes and their association with diabetic retinopathy: a 3-year follow-up study

Liu, Y., Sang, M., Yuan, Y., Du, Z., Li, W., Hu, H., Wen, L., Wang, F., Guo, H., Wang, B., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01872-5 · Cited by 9

Low agreement between radio binding assays in analyzing glutamic acid decarboxylase (GAD65Ab) autoantibodies in patients classified with type 2 diabetes

Daka, B., Svensson, M. K. E., Lernmark, Å., Mincheva‐Nilsson, L., Hallmans, G., & Rolandsson, O. (2009) · Autoimmunity · doi:10.1080/08916930902911720 · Cited by 9

Mania induced by high content caffeinated energy drinks.

Cruzado, L., Sánchez-Fernández, M., Cortez-Vergara, C. P., & Rojas-Rojas, G. (2014) · Actas Españolas de Psiquiatría · Cited by 9

Seroconversion to islet autoantibodies between early pregnancy and delivery in non-diabetic mothers

Lindehammer, S. R., Hansson, I., Midberg, B., Ivarsson, S. A., Lynch, K. F., Dillner, J., & Lernmark, Å. (2010) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2010.10.002 · Cited by 9

Long-term sustained autoimmune response to beta cell specific zinc transporter (ZnT8, W, R, Q) in young adult patients with preserved beta cell function at diagnosis of diabetes

Ingemansson, S., Vaziri‐Sani, F., Lindblad, U., Guðbjörnsdóttir, S., Törn, C., & on Behalf of the Diss-Study Group (2012) · Autoimmunity · doi:10.3109/08916934.2012.730585 · Cited by 9

Novel diagnostic and therapeutic approaches for autoimmune diabetes — A prime time to treat insulitis as a disease

Grönholm, J., & Lenardo, M. J. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.11.007 · Cited by 8

Latent Autoimmune Diabetes in Adults in North Indian Region: Assessment of β-Cell Function, Metabolic and Immunological Features

Kumar, A., & de Leiva, A. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0103 · Cited by 8

Diabetes mellitus

Sacks, D. B. (2012) · Tietz Textbook of Clinical Chemistry and Molecular Diagnostics · doi:10.1016/b978-1-4160-6164-9.00046-9 · Cited by 7

Phenotypic and environmental factors associated with elevated autoantibodies at clinical onset of paediatric type 1 diabetes mellitus

Ponsonby, A., Pezic, A., Cameron, F. J., Rodda, C. P., Ellis, J. A., Kemp, A. S., Carlin, J. B., & Dwyer, T. (2012) · Results in Immunology · doi:10.1016/j.rinim.2012.06.002 · Cited by 7

GADA testing: The current state of knowledge

Davies, H. A., Brophy, S. T., Bain, S., Stephens, J. W., LEWIS, J., Luzio, S. D., Dunseath, G. J., Beaverstock, C., & Williams, D. R. R. (2009) · Primary care diabetes · doi:10.1016/j.pcd.2009.07.002 · Cited by 7

ROFI - The Use of Repeated Optimization for Feature Interpretation

Webb‐Robertson, B., Bramer, L., Reehl, S., Metz, T., Zhang, Q., Rewers, M., & Frohnert, B. I. (2016) · International Conference on Computational Science and Computational Intelligence (CSCI) · doi:10.1109/csci.2016.0013 · Cited by 6

Mistaken Identity: The Role of Autoantibodies in Endocrine Disease

Nelson, H. A., Joshi, H. R., & Straseski, J. A. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab128 · Cited by 8

Pancreas Islet Cell-Specific Antibody Detection by ELISA

Aelst, S. V., Gillard, P., Weets, I., Dillaerts, D., Billen, J., Mathieu, C., & Bossuyt, X. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab141 · Cited by 7

Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 2020

Escobedo, R. R., Lambert, C., Morales-Sánchez, P., Delgado, E., & Torre, E. L. M. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01069-y · Cited by 8

Development of a fibrinogen-specific sandwich enzyme-linked immunosorbent assay microarray assay for distinguishing between blood plasma and serum samples

Gonzalez, R. M., Zhang, Q., Zangar, R. C., Smith, R. D., & Metz, T. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.02.039 · Cited by 7

Autoimmune (Type 1) Diabetes

Lindbladh, I., Svärd, A. A., & Lernmark, Å. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00041-5 · Cited by 8

Detecting autoreactive B cells in the peripheral blood of people with type 1 diabetes using ELISpot

Powell, W. E., Hanna, S. J., Hocter, C. N., Robinson, E., Lewis, M. D., Dunseath, G. J., Luzio, S. D., Howell, A., Dayan, C. M., & Wong, F. S. (2019) · Journal of Immunological Methods · doi:10.1016/j.jim.2019.05.007 · Cited by 7

The Level of Autoantibodies Targeting Eukaryote Translation Elongation Factor 1 α1 and Ubiquitin-Conjugating Enzyme 2L3 in Nondiabetic Young Adults

Kim, E. G., Kwak, S. H., Hwang, D., Yi, E. C., Park, K. S., Koo, B. K., & Kim, K. M. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.2.154 · Cited by 7

Novel prokaryotic expression of thioredoxin-fused insulinoma associated protein tyrosine phosphatase 2 (IA-2), its characterization and immunodiagnostic application

Guerra, L. L., Faccinetti, N. I., Trabucchi, A., Rovitto, B. D., Sabljic, A. V., Poskus, E., Iacono, R. F., & Valdez, S. N. (2016) · BMC Biotechnology · doi:10.1186/s12896-016-0309-2 · Cited by 7

Therapie des Typ-1-Diabetes – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-013; 2. Auflage)

Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2020) · Diabetologie und Stoffwechsel · doi:10.1055/a-1193-3724 · Cited by 7

A comparison of current methods to measure antibodies in type 1 diabetes

Infantino, M., Manfredi, M., Garrafa, E., Pancani, S., Lechiara, A., Mobilia, E. M., Grossi, V., Lari, B., Bizzaro, N., & Pesce, G. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2025-0238 · Cited by 6

Utility of Fasting C-Peptide for the Diagnostic Differentiation of Patients with Type 1, Type 2 Diabetes, MODY, and LADA

Alemán-Contreras, R., Gómez-Díaz, R. A., Noyola-García, M. E., Mondragón-González, R., Wacher, N. H., & Ferreira‐Hermosillo, A. (2024) · Life · doi:10.3390/life14050550 · Cited by 9

IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well as increased C-peptide levels in GADA positive gestational diabetes

Dereke, J., Nilsson, C., Strevens, H., Landin‐Olsson, M., & Hillman, M. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.11.001 · Cited by 6

Evaluation of the RSR 3 screen ICA™ and 2 screen ICA™ as screening assays for type 1 diabetes in Sweden

Törn, C., Vaziri‐Sani, F., Ramelius, A., Larsson, H. E., Ivarsson, S. A., Amoroso, M., Furmaniak, J., Powell, M. J., & Smith, B. R. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01856-5 · Cited by 6

Autoantibodies against zinc transporter 8 further stratify the autoantibody‐defined risk for type 1 diabetes in a general population of schoolchildren and have distinctive isoform binding patterns in different forms of autoimmune diabetes: results from the Karlsburg Type 1 Diabetes Risk Study

Baumann, K., Kesselring, K., Lampasona, V., Walschus, U., Kerner, W., Waßmuth, R., & Schlosser, M. (2020) · Diabetic Medicine · doi:10.1111/dme.14389 · Cited by 6

Clinical, biochemical, and immunological characteristics of newly diagnosed nonobese diabetic patients aged 18–45 years in China

Shi, Z., Sun, Q., Feng, K., Fu, Y., Wang, O., Ping, F., & Li, Y. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.11.009 · Cited by 6

Biomarkers in diabetes mellitus: Advancements, challenges, and future perspectives

Prajapati, A. K., Jha, A. K., & Sheth, D. B. (2024) · IP International Journal of Comprehensive and Advanced Pharmacology · doi:10.18231/j.ijcaap.2024.012 · Cited by 5

Therapie des Typ-1-Diabetes – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-013; 4. Auflage 2018)

Haak, T., Gölz, S., Fritsche, A., Füchtenbusch, M., Siegmund, T., Schnellbächer, E., Klein, H. H., Uebel, T., & Droßel, D. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/a-2075-9984 · Cited by 5

Autoimmune Diabetes Mellitus: The Importance of Autoantibodies for Disease Prediction and Diagnostic Support

Valdez, S. N., & Poskus, E. (2010) · Current Immunology Reviews · doi:10.2174/1573395511006040299 · Cited by 5

Pancreatic autoantibodies: who to test and how to interpret the results

Misra, S. (2017) · Practical Diabetes · doi:10.1002/pdi.2123 · Cited by 5

Epidemiology and risk factors for type 1 diabetes mellitus

Steck, A. K., & Rewers, M. J. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch2 · Cited by 5

Autoimmune Type 1 Diabetes

Alshiekh, S., Larsson, H. E., Ivarsson, S. A., & Lernmark, Å. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch10 · Cited by 5

Marcadores inmunológicos de diabetes tipo 1: análisis de 4.164 perfiles en un centro de salud de Chile

Vera, F., Jofré, P., Rodríguez, D., Lagos, R., Quiroga, T., Grassi, B. A., & Felipe Pollak, C. (2021) · Revista médica de Chile · doi:10.4067/s0034-98872021000300330 · Cited by 4

Improving diagnostic accuracy of 3 Screen ICA ELISA kit in the identification of Japanese type 1 diabetes

Kawasaki, E., Jinnouchi, H., Maeda, Y., Okada, A., Ito, Y., & Kawai, K. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14038 · Cited by 4

Prevalence of Positivity for Diabetes-Associated Autoantibodies in Individuals with Type 2 Diabetes and Their Further Characterisation: Cross-sectional Study from Slovakia

Rončáková, M., Davani, A., Mikušová, V., Ságová, I., Novodvorský, P., & Martinka, E. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01440-2 · Cited by 5

Therapie des Typ-1-Diabetes

Haak, T., Fritsche, A., Füchtenbusch, M., Gehr, B., Gölz, S., Kröger, J., Siegmund, T., Ziegler, R., Droßel, D., Fuchs, S., et al. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2312-0276 · Cited by 4

Experience of the introduction of routine antibody testing in primary care and of running a trial for latent autoimmune diabetes in adults (LADA)

Brophy, S. T., Davies, H. A., Dunseath, G. J., Stephens, J. W., Platts, J. K., Lane, H., Beaverstock, C., Wakeman, L. J., Russell, I. T., Williams, M., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.04.004 · Cited by 4

Is there evidence for post-translational modification of beta cell autoantigens in the aetiology and pathogenesis of type 1 diabetes?

Lernmark, Å. (2013) · Diabetologia · doi:10.1007/s00125-013-3041-7 · Cited by 4

Insulin resistance relates to DKA severity and affects insulin requirement in children with type 1 diabetes at onset

Mastromauro, C., Polidori, N., Blasetti, A., Comegna, L., Chiarelli, F., Mohn, A., & Giannini, C. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13424 · Cited by 4

GAD and IA-2 autoantibody detection in type 1 diabetic patient saliva

Tiberti, C., Shashaj, B., Verrienti, A., Vecci, E., Lucantoni, F., Masotti, D., Morano, S., Sulli, N., & Dotta, F. (2009) · Clinical Immunology · doi:10.1016/j.clim.2008.12.002 · Cited by 4

Comparison of Measurements of Autoantibodies to Glutamic Acid Decarboxylase and Islet Antigen-2 in Whole Blood Eluates from Dried Blood Spots Using the RSR-Enzyme Linked Immunosorbent Assay Kits and In-House Radioimmunoassays

Persson, A., Becker, C., Hansson, I., Nilsson, A., & Törn, C. (2010) · Experimental Diabetes Research · doi:10.1155/2010/173652 · Cited by 4

Islet Autoantibody Standardization Program 2018 workshop: interlaboratory comparison of glutamic acid decarboxylase autoantibody assay performance

Lampasona, V., Pittman, D. L., Williams, A. J., Achenbach, P., Schlosser, M., Akolkar, B., Winter, W. E., Laboratories, P., Watson, K., Weets, I., et al. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.304196 · Cited by 103

Diabetes Antibody Standardization Program First evaluation of assays for autoantibodies to IA-2b

Schlosser, M., Mueller, P. W., Achenbach, P., Bsc, V. L., & Bingley, P. J. (2016)

Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies

Laboratories, P., Schlosser, M., Mueller, P. W., Törn, C., Bonifacio, E. E., & Bingley, P. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1915-5 · Cited by 180

Diabetes Antibody Standardization Program: first assay proficiency evaluation

Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362

Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops

Marzinotto, I., Pittman, D. L., Williams, A. J. K., Long, A. E., Achenbach, P., Schlosser, M., Akolkar, B., Winter, W. E., Lampasona, V., & laboratories, P. (2023) · Diabetologia · doi:10.1007/s00125-023-05877-9 · Cited by 66